Burden of Disease is Positively Associated with Disease Severity in Atopic Dermatitis.
Burden of Disease is Positively Associated with Disease Severity in Atopic Dermatitis (RAD 2021)
Challenge
This is the RAD 2021 poster—the earliest presentation—of the burden-by-severity findings that were subsequently published in manuscript form (Row 11) and presented at Fall Clinical 2022 (Row 36). First dissemination of the finding that vIGA-AD severity is strongly associated with patient-reported symptom and QoL burden.
Solution
TARGET-DERM AD cohort analysis of vIGA-AD/PRO correlations at RAD 2021, providing the initial real-world validation of the clinician-patient burden relationship in AD.
Impact
RAD 2021 presentation initiates the multi-venue dissemination of the vIGA-AD/PRO correlation evidence, establishing the real-world foundation for clinician and PRO endpoint validation in AD that supports regulatory and commercial strategy across multiple AD development programs.
